Palo Protocol
Metabolic Stack — 5-Amino-1MQ + SLU-PP-332
Metabolic
50 mg / 1 mg · 30 capsules
The combination people ask us about most. Both compounds sit upstream of the same metabolic machinery, and both remain preclinical. We will not sell either until the pathway is properly built.
Not available for purchase
What we know
- Mechanism
- Pairs NNMT inhibition with an ERR-alpha agonist that upregulates the transcriptional programme associated with endurance exercise.
- Evidence state
- Preclinical. Rodent data only; no human trials.
- Regulatory note
- Neither component is an approved drug or established dietary ingredient. Prescriber pathway only.
Disclaimer
This product is not available for purchase. It has not been evaluated by the FDA and is not intended to diagnose, treat, cure or prevent any disease. Nothing on this page is medical advice. Palo lists this compound for transparency about our supply partnerships; any future availability would run through a licensed prescriber and a compounding pharmacy, not through this website.